• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类对牛促甲状腺激素的反应:简要通讯

Human reaction to bovine TSH: concise communication.

作者信息

Krishnamurthy G T

出版信息

J Nucl Med. 1978 Mar;19(3):284-6.

PMID:632904
Abstract

The incidence of allergic reactions to bovine TSH and its relation to dose have been studied in 42 patients with thyroid cancer who had total ablation of functioning thyroidal tissue and have been followed prospectively for up to 25 yr. Of these patients, 43% showed an allergic reaction to bovine TSH. The remaining 57% have shown no reaction, even though they have received cumulative TSH doses larger than those who did show a reaction. The reaction rate is linear up to a cumulative dose of 150 units and is not dose-related therafter.

摘要

在42例甲状腺癌患者中,研究了对牛促甲状腺素(TSH)过敏反应的发生率及其与剂量的关系。这些患者功能性甲状腺组织已全部切除,并进行了长达25年的前瞻性随访。在这些患者中,43%对牛TSH有过敏反应。其余57%未出现反应,尽管他们接受的TSH累积剂量大于出现反应的患者。反应率在累积剂量达150单位之前呈线性,之后与剂量无关。

相似文献

1
Human reaction to bovine TSH: concise communication.人类对牛促甲状腺激素的反应:简要通讯
J Nucl Med. 1978 Mar;19(3):284-6.
2
Follow-up of differentiated thyroid cancers after treatment. Resume and practical guide for the development of follow-up programs.
Ann Radiol (Paris). 1977 Nov-Dec;20(8):841-55.
3
The significance of I-131 scan doses in patients with thyroid cancer: determination of ablation: concise communication.I-131扫描剂量在甲状腺癌患者中的意义:消融的确定:简要通讯
J Nucl Med. 1982 Apr;23(4):363-4.
4
Radioiodine treatment with 30 mCi after recombinant human thyrotropin stimulation in thyroid cancer: effectiveness for postsurgical remnants ablation and possible role of iodine content in L-thyroxine in the outcome of ablation.重组人促甲状腺素刺激后用30毫居里放射性碘治疗甲状腺癌:对术后残留组织消融的有效性以及左旋甲状腺素中碘含量在消融结果中的可能作用。
J Clin Endocrinol Metab. 2003 Sep;88(9):4110-5. doi: 10.1210/jc.2003-030298.
5
Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up.接受重组人促甲状腺激素或甲状腺激素停药后低活度¹³¹I 放射性碘甲状腺残余消融治疗的分化型甲状腺癌患者,在 10 年随访后具有相同的结果。
J Clin Endocrinol Metab. 2013 Jul;98(7):2693-700. doi: 10.1210/jc.2012-4137. Epub 2013 Apr 26.
6
[TSH stimulation at low doses in the diagnosis of autonomous adenoma: accuracy and risk of the TSH test (author's transl)].低剂量促甲状腺激素刺激试验在自主性腺瘤诊断中的应用:促甲状腺激素检测的准确性及风险(作者译)
Dtsch Med Wochenschr. 1974 Jun 7;99(23):1236-9. doi: 10.1055/s-0028-1107923.
7
TSH stimulation and other ways to increase the uptake in normal and tumorous thyroidal tissue.
Czech Med. 1982;5(2):90-103.
8
Iodine biokinetics and radioiodine exposure after recombinant human thyrotropin-assisted remnant ablation in comparison with thyroid hormone withdrawal.重组人促甲状腺激素辅助残余消融后碘生物动力学和放射性碘暴露与甲状腺激素停药的比较。
J Clin Endocrinol Metab. 2010 Jul;95(7):3283-90. doi: 10.1210/jc.2009-2528. Epub 2010 Apr 14.
9
Ablation of thyroid residues with 30 mCi (131)I: a comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal.用30毫居里的碘-131消融甲状腺残留组织:重组人促甲状腺素或甲状腺激素撤药准备的甲状腺癌患者的比较。
J Clin Endocrinol Metab. 2002 Sep;87(9):4063-8. doi: 10.1210/jc.2001-011918.
10
Pharmacology of bovine and human thyrotropin: an historical perspective.牛和人促甲状腺激素的药理学:历史视角
Thyroid. 1999 May;9(5):451-3. doi: 10.1089/thy.1999.9.451.

引用本文的文献

1
Characterization of recombinant human and bovine thyroid-stimulating hormone preparations by mass spectrometry and determination of their endotoxin content.采用质谱法对重组人及重组牛促甲状腺激素制剂进行特征分析,并测定其内毒素含量。
BMC Vet Res. 2013 Jul 16;9:141. doi: 10.1186/1746-6148-9-141.
2
Recombinant thyrotropin for detection of recurrent thyroid cancer.重组促甲状腺素用于复发性甲状腺癌的检测。
Trans Am Clin Climatol Assoc. 2002;113:21-30.